DURECT ($DRRX) posted quarterly earnings results on Wednesday, March 26th. The company reported earnings of -$0.06 per share, missing estimates of -$0.02 by $0.04. The company also reported revenue of $450,000, missing estimates of $7,044,803 by $-6,594,803.
You can see Quiver Quantitative's $DRRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DURECT Hedge Fund Activity
We have seen 17 institutional investors add shares of DURECT stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INGALLS & SNYDER LLC removed 393,767 shares (-19.8%) from their portfolio in Q4 2024, for an estimated $295,325
- RICHMOND BROTHERS, INC. added 138,920 shares (+12.2%) to their portfolio in Q4 2024, for an estimated $104,190
- ACCREDITED INVESTORS INC. added 88,570 shares (+2644.7%) to their portfolio in Q4 2024, for an estimated $66,427
- BEIRNE WEALTH CONSULTING SERVICES, LLC removed 50,501 shares (-13.4%) from their portfolio in Q4 2024, for an estimated $37,875
- CITADEL ADVISORS LLC removed 42,179 shares (-56.5%) from their portfolio in Q4 2024, for an estimated $31,634
- GSA CAPITAL PARTNERS LLP removed 41,790 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $31,342
- UBS GROUP AG added 30,647 shares (+1761.3%) to their portfolio in Q4 2024, for an estimated $22,985
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
